Breast Cancer
Share Your Story
If you have you been affected by breast cancer and want to help raise awareness, find out about sharing your story.
Institute Research Highlights
- Covert Cancer Drugs ‘Fast Tracked’ To Tumours
- Early Trials Of Cancer Drug Show Promise
- Scientists Shed Light on Tamoxifen Risks
- ICR Scientists Reveal Structure of HSP90
- Scientists Unravel Breast Cancer Risk Gene Mystery
Show all Breast Cancer Institute Research Highlights
Institute Research Teams
-
Tumour Biology and Metastasis Team
Our research relates to the cellular processes involved in invasion and metastasis and their potential as therapeutic targets in cancer. We have a particular interest in glioma, prostate carcinoma and squamous carcinomas of the head and neck. The molecular machinery of tumour cell invasion and neoangiogenesis has many common components, and may provide more selective (or additional) targets for therapeutic intervention compared with cell proliferation. We have established a comprehensive panel of assays of in vitro and in vivo angiogenesis, invasion and metastasis for evaluation of novel inhibitors emerging from the Centre's drug discovery programme and other basic science and translational collaborations. -
Cancer Screening Evaluation Unit (DoH)
Screening is one of the major areas of health care for cancer in England. The research carried out by Cancer Screening Evaluation Unit includes the e. -
CR-UK Epidemiology & Genetics Unit
The Cancer Research UK Epidemiology and Genetics Group is based at the Institute of Cancer Research and the London School of Hygiene and Tropical Medicine. It comprises cancer epidemiologists, statisticians, laboratory-based scientists, research nurses and other support staff. -
Biochemical Endocrinology Team
The remit of this team is to apply endocrine analyses firstly to optimise the use of new hormonal agents, either alone or in combination with other agents, for use in breast cancer and secondly to participate in epidemiological studies of breast (and other) cancer risk. Over the years the team has conducted a very large number of studies in the area of drug development, with particular emphasis on aromatase inhibitors. -
Molecular Endocrinology Team
This group conducts a number of studies in the molecular biology of breast cancer which are expected to have significant clinical parallels. A dominant feature is our interest in the mechanisms which underpin hormonal resistance in breast cancer cells.
